KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amphenol (APH) Shares Outstanding (Weighted Average) (2016 - 2025)

Amphenol (APH) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 1.2% to $1.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Dec 2025, up 1.2% year-over-year, with the annual reading at $1.2 billion for FY2025, 1.2% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $1.2 billion in Q4 2025 for Amphenol, roughly flat from $1.2 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.2 billion in Q3 2025 to a low of $595.1 million in Q1 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $960.7 million across 5 years, with a median of $1.2 billion in 2022.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): fell 0.53% in 2023 and later skyrocketed 101.65% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $597.9 million in 2021, then surged by 99.41% to $1.2 billion in 2022, then rose by 0.06% to $1.2 billion in 2023, then rose by 0.91% to $1.2 billion in 2024, then rose by 1.2% to $1.2 billion in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for APH at $1.2 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.2 billion in Q2 2025.